Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes

Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes

Abstract Background In addition to improving survival outcomes, new oncology treatments should lead to amelioration of patients’ quality of life (QoL). Herein, we examined whether QoL results correlated with PFS and OS outcomes in phase III randomized controlled trials (RCTs) investigating new syste...

Full description

Bibliographic Details
Main Authors: Alberto Servetto, Massimo Di Maio, Fabio Salomone, Fabiana Napolitano, Chiara Paratore, Fabrizio Di Costanzo, Giuseppe Viscardi, Antonio Santaniello, Luigi Formisano, Roberto Bianco
Format: Article
Language:English
Published: BMC 2023-07-01
Series:BMC Medicine
Subjects:
QoL
Quality of life
Metastatic NSCLC
Lung cancer
PROs
Patient reported outcomes
Online Access:https://doi.org/10.1186/s12916-023-02953-0

Internet

https://doi.org/10.1186/s12916-023-02953-0

Similar Items